00d:00h:00m:00s
AI Growth Summit: 9 Tactics to Add $10m FastJune 30
121/150seats takenSave Your Seat
Latka logo

Oxford Drug Design Revenue & Funding (2024)

InhibOx is a pioneer in the development and application of new technologies to drive drug discovery. Their multidisciplinary research team has brought together breakthroughs in computational chemistry, cheminformatics, mathematics, cloud computing and software-as-a-service (SaaS) delivery methods to create DrugFinder: the next generation drug discovery platform.

Last updated

Oxford Drug Design Revenue

In 2024, Oxford Drug Design's revenue reached $2.7M. The company previously reported $1.4M in 2023. Since its launch in 2001, Oxford Drug Design has shown consistent revenue growth.

Oxford Drug Design Revenue GrowthReported revenue / ARR over time · latest figure estimated$0$600K$1.2M$1.8M$2.4M$3M2001200320052007200920112013201520172019202120232024$0$709.9K$2.7MSource: GetLatka.com
YearMilestoneSource
2024Oxford Drug Design Hit $2.7m revenue in October 2024Estimated
2023Oxford Drug Design Hit $1.4m revenue in November 2023Estimated
2022Oxford Drug Design Hit $1.1m revenue in November 2022
2021Oxford Drug Design Hit $709.9k revenue in November 2021
2001Launched with $0 revenue

Oxford Drug Design Valuation, Funding Rounds

Oxford Drug Design has not publicly disclosed its valuation. The company has raised $12.4M in total funding to date.

Oxford Drug Design has raised $12.4M in total funding across 5 rounds, most recently a $2.7M Convertible Note round in 2022.

Oxford Drug Design Capital Raised & ValuationCumulative capital raised and post-money valuation by roundCapital raised (cum.)Valuation$0$0$0.2$3M$0.4$6M$0.6$9M$0.8$12M$1$15M200120032005200720092011201320152017201920212022Source: GetLatka.com
YearRoundAmountValuation% SoldSource
2022Convertible Note$2.7M--
2019Venture Round$2.7M--
2019Grant$3.2M--
2017Series A$1.2M--
2006Venture Round$2.4M--

Founder / CEO

Graham Richards

CEO

Graham Richards is listed as CEO at Oxford Drug Design.

Q&A

QuestionAnswer
What's your age?-
Favorite online tool?-
Favorite book?-
Favorite CEO?-
Advice for 20 year old self-

Customers

We do not have customer count information for Oxford Drug Design yet.

Oxford Drug Design Employees & Team Size

Oxford Drug Design employs approximately 11 people as of 2026.

Oxford Drug Design Team GrowthReported headcount over time06121824302001200320052007200920112013201520172019202120232024001111Source: GetLatka.com
YearMilestoneSource
2024Reached 11 employees (October 2024)
2023Reached 11 employees (November 2023)
2022Reached 9 employees (November 2022)
2022Reached 9 employees (May 2022)
2021Reached 7 employees (November 2021)
2021Reached 25 employees (April 2021)
2020Reached 7 employees (November 2020)

Frequently Asked Questions about Oxford Drug Design

What is Oxford Drug Design's revenue?

Oxford Drug Design generates an estimated $2.7M in annual revenue.

Who founded Oxford Drug Design?

Oxford Drug Design was founded by Graham Richards.

Who is the CEO of Oxford Drug Design?

The CEO of Oxford Drug Design is Graham Richards.

How much funding does Oxford Drug Design have?

Oxford Drug Design raised $12.4M across 5 rounds.

How many employees does Oxford Drug Design have?

Oxford Drug Design has 11 employees.

Where is Oxford Drug Design headquarters?

Oxford Drug Design is headquartered in Oxford, United Kingdom.

Compare Oxford Drug Design to the industry

Oxford Drug Design operates across multiple industries. Browse revenue, funding, and growth data for Oxford Drug Design in each sector below.

Data and Sources

All figures on this page are taken directly from interviews or are estimates from public sources and proprietary models. Not financial advice. Read full disclaimer.

Claim this profile
Oxford Drug Design Revenue 2024: $2.7M Est. ARR